MedTrace Logo

Nerve Transfer to Improve Function in High Level Tetraplegia

NCT06288763 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2026-03-11

No results posted yet for this study

Summary

The goal of this observational study is to determine if nerve transfer surgeries improve upper extremity function and quality of life in patients with a high level cervical spinal cord injury.

Participants will:

* undergo standard of care pre- and post-op testing and study exams
* complete pre- and post-questionnaires
* undergo standard of care nerve transfer surgeries
* follow-up with surgeon at 6/12/18/24/36 and potentially at 48 months
* attend therapy at local therapist for up to 2 years postop.

Conditions

  • Tetraplegia
  • Cervical Spinal Cord Injury

Sponsors & Collaborators

  • University of Michigan

    collaborator OTHER

  • The Methodist Hospital Research Institute

    collaborator OTHER

  • University of Pennsylvania

    collaborator OTHER

  • University of Utah

    collaborator OTHER

  • Stanford University

    collaborator OTHER

  • University of Miami

    collaborator OTHER

  • Johns Hopkins University

    collaborator OTHER

  • University of Alberta

    collaborator OTHER

  • Wake Forest University Health Sciences

    collaborator OTHER

  • Department of Defense / Congressionally Mandated Research Program (CDMRP)

    collaborator UNKNOWN

  • Washington University School of Medicine

    lead OTHER

Principal Investigators

  • Wilson Z. Ray, MD · Washington University School of Medicine

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-05
Primary Completion
2028-03-01
Completion
2028-12-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06288763 on ClinicalTrials.gov